Literature DB >> 15154573

Living related liver transplantation in adults: first year experience at the University of Liège.

O Detry1, A De Roover, J Delwaide, C Coimbra, A Kaba, J Joris, P Damas, M Meurisse, P Honoré.   

Abstract

Living related liver transplantation (LRLT) in adult recipients has been recently developed to overcome the organ donor shortage, but LRLT leaves the healthy donors at risk of serious post-operative complications, or even death. The aim of this paper is to report the prospective evaluation of the initial experience of adult LRLT at the University of Liège. From March 2002 till March 2003, in a consecutive series of 35 adult liver transplantations, five recipients (mean age: 51 years) underwent LRLT, including one retransplantation. Indications for transplantation were autoimmune hepatitis, hepatitis B virus related cirrhosis with hepatocarcinoma (two cases), hepatitis C virus related cirrhosis with hepatocarcinoma, and ischemic intrahepatic bile duct necrosis 10 years after primary liver transplantation. Mean age of the donors was 34 years (range: 21-53 years). All donation cases were intra familial at first degree. The right lobe was used as a graft in four cases and the left lobe in one case. All right lobe donors developed transient hyperbilirubinemia and hypocoagulation for 4 to 6 days. No severe complication (transfusion, bile duct fistula, reintervention, rehospitalization) nor significant long-term sequelae were observed in the donors. In the recipients, graft function was immediate, and there was no small-for-size syndrome. One recipient developed biliary fistula treated by reoperation. One recipient died from invasive aspergillosis 11 days after the procedure. The four other recipients were alive without recurrence of the disease at follow-up. This report confirmed that LRLT may be a valuable alternative to cadaveric liver transplantation in the era of organ donor shortage. However, even if there was no severe complication for the donors in our preliminary experience, LRLT puts healthy living donors at risk of significant morbidity and even death.

Entities:  

Mesh:

Year:  2004        PMID: 15154573     DOI: 10.1080/00015458.2004.11679529

Source DB:  PubMed          Journal:  Acta Chir Belg        ISSN: 0001-5458            Impact factor:   1.090


  2 in total

1.  Prognostic value of (18)F-FDG PET/CT in liver transplantation for hepatocarcinoma.

Authors:  Olivier Detry; Laurence Govaerts; Arnaud Deroover; Morgan Vandermeulen; Nicolas Meurisse; Serge Malenga; Noella Bletard; Charles Mbendi; Anne Lamproye; Pierre Honoré; Paul Meunier; Jean Delwaide; Roland Hustinx
Journal:  World J Gastroenterol       Date:  2015-03-14       Impact factor: 5.742

2.  Cadaveric liver transplantation for non-acetaminophen fulminant hepatic failure: a 20-year experience.

Authors:  Olivier Detry; Arnaud De Roover; Carla Coimbra; Jean Delwaide; Marie-France Hans; Marie-Hélène Delbouille; Joseé Monard; Jean Joris; Pierre Damas; Jacques Belaïche; Michel Meurisse; Pierre Honoré
Journal:  World J Gastroenterol       Date:  2007-03-07       Impact factor: 5.742

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.